Clinical Trial Update: Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial comparing rosuvastatin and atorvastatin in hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Bader, Ted, M.D. | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED